Research finds Kava safe and effectiveMay 12, 2009Extract of Kava useful in treating anxiety and improving mood Researchers at the University of Queensland in Australia have found a traditional extract of Kava, a medicinal plant from the South Pacific, to be safe and effective in reducing anxiety. To be published online this week in the Springer journal Psychopharmacology, the results of a world-first clinical trial which found that a water-soluble extract of Kava was effective in treating anxiety and improving mood. The Kava was prescribed in the form of tablets. Lead researcher Jerome Sarris, a PhD candidate from UQ's School of Medicine, said the placebo-controlled study found Kava to be an effective and safe treatment option for people with chronic anxiety and varying levels of depression. "We've been able to show that Kava offers a natural alternative for the treatment of anxiety, and unlike some pharmaceutical options, has less risk of dependency and less potential of side effects," Mr. Sarris said. Each week participants were given a clinical assessment as well as a self-rating questionnaire to measure their anxiety and depression levels. The researchers found anxiety levels decreased dramatically for participants taking five tablets of Kava per day as opposed to the placebo group which took dummy pills. "We also found that Kava had a positive impact on reducing depression levels, something which had not been tested before," Mr. Sarris said. In 2002 Kava was banned in Europe, UK and Canada due to concerns over liver toxicity. While the three-week trial raised no major health concerns regarding the Kava extract used, the researchers said larger studies were required to confirm the drug's safety. "When extracted in the appropriate way, Kava may pose less or no potential liver problems. I hope the results will encourage governments to reconsider the ban," Mr. Sarris said. "Ethanol and acetone extracts, which sometimes use the incorrect parts of the Kava, were being sold in Europe. That is not the traditional way of prescribing Kava in the Pacific Islands. Our study used a water-soluble extract from the peeled rootstock of a medicinal cultivar of the plant, which is approved by the Therapeutic Goods Administration of Australia and is currently legal in Australia for medicinal use." Reference 1. Sarris J et al. (2009). The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology. DOI 10.1007/s00213-009-1549-9 Springer |
|||||||||||||||||||||
| Related Kava Current Events and Kava News Articles University of Sydney researchers find new evidence linking kava to liver damage In recent years, serious concerns about the dangers of kava and the effects on the liver have resulted in regulatory agencies, such as the US Food and Drug Administration and Australia's Therapeutic Goods Administration, banning or restricting the sale of kava and kava products. Herbal supplements, a smoking gun in plastic surgery Natural herbal supplements are supposed to help boost our immune systems, give us more energy and make us generally healthier. Even Babies Can Have Optical Illusions At the tender age of five months babies can be fooled by complex information about distances in drawings involving perspective, psychologists from the University of Bonn have shown. They fixed two rubber figures onto a picture on which a chessboard pattern appeared to be receding away from the babies. The babies then tried to grab the toy which seemed nearer to them because of the information on distance implied by the drawing. This effect was even noticed in some cases in five-month-old children. Previously most experts had assumed that babies cannot decipher data on distance which are based on perspective until much later. Innovation as the basis for regional development in EU candidate countries - a strategic approach A series of events across central and eastern Europe will show how consensus-based strategic planning is already helping 20 candidate country regions to revitalise their economies through innovation. Substantial EU funding will soon be available to other regions that wish to follow the same path to competitiveness. The purpose of the events: ·overview of European Commission policy to promote regional innovation ·introduction to the Europe-wide IRE network for innovating regions ·regional development in the host country ·case studies of previous Regional Innovation Strategy projects ·advice on how to take maximum advantage of available EU funding for regions ·the spring 2004 call for pr £500,000 Donation for Complementary Medicine at Peninsula Medical School A donation of £500,000 has been made by the Maurice Laing Foundation to fund the Peninsula Medical School's Chair in Complementary Medicine, held by Professor Edzard Ernst. This is the second major gift made by the Maurice Laing Foundation to Complimentary Medicine at the Peninsula Medical School. It represents a total donation to the School of £2,000,000. The Complementary Medicine Research Group is the largest of its kind in Europe with a sixteen-strong research team. It conducts a wide-ranging research programme into Complementary and Alternative Medical treatments, such as herbal remedies, homoeopathy, osteopathy and acupuncture. Its recent work included monitoring 30,000 acu More Kava Current Events and Kava News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||